Phase 3 study of guselkumab, a human mAb directed against the p19 subunit of IL23, in Japanese subjects with generalized pustular psoriasis and erythrodermic psoriasis

Saved in:
Bibliographic Details
Published inJournal of the American Academy of Dermatology Vol. 76; no. 6; p. AB196
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.06.2017
Subjects
Dermatology
Online AccessGet full text
ISSN0190-9622
1097-6787
DOI10.1016/j.jaad.2017.04.766

Cover

More Information
ISSN:0190-9622
1097-6787
DOI:10.1016/j.jaad.2017.04.766